Alpha 2.0
Login Register
» Authors » Ghadeer Hasan

Ghadeer Hasan

Explore the profile of Ghadeer Hasan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 102
Followers 0
Related Specialty
Rheumatology
Top 10 Co-Authors
Jill P Buyon
H Michael Belmont
Peter M Izmirly
Ilaria Galetti
Chaim Putterman
Anna Baritussio
Alexis J Engel
Sven Plein
Luna Gargani
George Markousis-Mavrogenis
Published In
J Scleroderma Relat Disord
Arthritis Rheumatol
Rheumatology (Oxford)
Arthritis Res Ther
Lancet Rheumatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus
Joyce D, Berger J, Guttmann A, Hasan G, Buyon J, Belmont H, et al.
Arthritis Res Ther . 2024 Sep; 26(1):160. PMID: 39272198
Background: The Manhattan Lupus Surveillance Program (MLSP), a population-based retrospective registry of patients with systemic lupus erythematosus (SLE), was used to investigate the prevalence of cardiovascular disease events (CVE) and...
2.
Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment
Bruni C, Buch M, Djokovic A, Luca G, Dumitru R, Giollo A, et al.
J Scleroderma Relat Disord . 2023 Sep; 8(3):169-182. PMID: 37744047
Introduction: Heart involvement is a common problem in systemic sclerosis. Recently, a definition of systemic sclerosis primary heart involvement had been proposed. Our aim was to establish consensus guidance on...
3.
Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program
Hasan G, Ferucci E, Buyon J, Belmont H, Salmon J, Askanase A, et al.
Rheumatology (Oxford) . 2022 Dec; 62(8):2845-2849. PMID: 36538873
Objective: Epidemiological data for MCTD are limited. Leveraging data from the Manhattan Lupus Surveillance Program (MLSP), a racially/ethnically diverse population-based registry of cases with SLE and related diseases including MCTD,...
4.
Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
Saxena A, Engel A, Banbury B, Hasan G, Fraser N, Zaminski D, et al.
Lancet Rheumatol . 2022 Jul; 4(9):e582-e585. PMID: 35856060
No abstract available.
5.
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition
Bruni C, Buch M, Furst D, Luca G, Djokovic A, Dumitru R, et al.
J Scleroderma Relat Disord . 2022 Apr; 7(1):24-32. PMID: 35386946
Introduction: Primary heart involvement in systemic sclerosis may cause morpho-functional and electrical cardiac abnormalities and is a common cause of death. The absence of a clear definition of primary heart...
6.
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination
Izmirly P, Kim M, Samanovic M, Fernandez-Ruiz R, Ohana S, Deonaraine K, et al.
Arthritis Rheumatol . 2021 Aug; 74(2):284-294. PMID: 34347939
Objective: To evaluate seroreactivity and disease flares after COVID-19 vaccination in a multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods: Ninety SLE patients and 20 healthy controls receiving...